Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
ARDS
•
Hospital Medicine
Do you use spO2 to define ARDS in patients with darker skin pigmentation?
Related Questions
Do you consider use of convalescent plasma early in disease course in COVID-19 induced ARDS in mechanically ventilated patients?
How do you decide whether to use lung POCUS versus CT as the next step when a chest X-ray is equivocal for pneumonia?
In a patient with acute stroke/ICH/SDH/hyperammonemia at risk for rebound edema with new onset renal failure, do you prefer CRRT versus low and slow HD? How frequently do you monitor osmolarity?
Is the adage “If GCS <8, intubate” still relevant for non-TBI patients?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
Do shorter door-to-balloon (D2B) times impact outcomes in STEMI, if it's already less than 90 minutes, and to what degree (i.e., 30 vs 60 minutes would have a more significant impact)?
Is there a subset of patients in whom pre-oxygenation with NRB or BVM could be safely pursued?
What are some important considerations for use of ACE inhibition in scleroderma renal crisis patients who require dialysis?
What is the upper limit of blood glucose target in hyperglycemic critically ill patients?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
